Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
2
×
life sciences
national blog main
new york blog main
2
×
san diego blog main
2
×
san diego top stories
achaogen
adams street partners
alder biopharmaceuticals
amgen
antibiotics
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
david rind
deals
detroit blog main
detroit top stories
drug resistance
drugs
eli lilly
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
hatteras venture partners
indiana blog main
indiana top stories
institute for clinical and economic review
investing
lyzz capital
What
drug
2
×
medicines
2
×
amgen
approval
bacteria
biopharma
business
candidates
class
company
developed
disease
exited
fda
fighting
gets
head
infections
infectious
launches
melinta
migraine
new
nod
pain
preventive
products
qpex
resistant
sold
starts
tackle
therapeutics
won
year
Language
Current search:
fda
×
drug
×
" san diego blog main "
×
medicines
×
" new york blog main "
×
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
